Home
Sai Life Sciences Ltd PE Ratio

Sai Life Sciences Ltd
NSE: SAILIFE
PE
Key Highlights
- The P/E Ratio of Sai Life Sciences Ltd is 101.2 as of 19 Feb 15:30 PM .
- The P/E Ratio of Sai Life Sciences Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
- The Latest Trading Price of Sai Life Sciences Ltd is ₹ 669.95 as of 19 Feb 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Sai Life Sciences Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Sai Life Sciences Ltd
Company Fundamentals for Sai Life Sciences Ltd

Sai Life Sciences Ltd
NSE: SAILIFE
Share Price
Market Price of Sai Life Sciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
18 Feb 2025 | 670.9 |
17 Feb 2025 | 668.6 |
14 Feb 2025 | 660.55 |
13 Feb 2025 | 679.75 |
12 Feb 2025 | 678.7 |
11 Feb 2025 | 677.8 |
10 Feb 2025 | 718.55 |
07 Feb 2025 | 749.2 |
06 Feb 2025 | 740.65 |
05 Feb 2025 | 692.5 |
SWOT Analysis Of Sai Life Sciences Ltd
BlinkX Score for Sai Life Sciences Ltd
Asset Value vs Market Value of Sai Life Sciences Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Sai Life Sciences Ltd | 13954 | 101.19 |
Sun Pharmaceuticals Industries Ltd | 408259 | 34.6 |
Divis Laboratories Ltd | 154917 | 74.9 |
Cipla Ltd | 119705 | 24.0 |
Torrent Pharmaceuticals Ltd | 103096 | 55.4 |
Dr Reddys Laboratories Ltd | 99951 | 18.6 |
Company | |
---|---|
Sai Life Sciences Ltd | 13954 |
Sun Pharmaceuticals Industries Ltd | 408259 |
Divis Laboratories Ltd | 154917 |
Cipla Ltd | 119705 |
Torrent Pharmaceuticals Ltd | 103096 |
Dr Reddys Laboratories Ltd | 99951 |
PE Ratio of Sai Life Sciences Ltd Explained
₹13954
Market cap
₹137
Earnings
101.2X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Sai Life Sciences Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Sai Life Sciences Ltd
Historical Revenue, EBITDA and Net Profit of Sai Life Sciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Sai Life Sciences Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Sai Life Sciences Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Sai Life Sciences Ltd
About Sai Life Sciences Ltd
- Sai Life Sciences Limited was originally incorporated as Sai Dru Syn Laboratories Limited' as a Public Limited Company, dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
- The Company received the Certificate of Commencement of Business from Registrar of Companies, Andhra Pradesh on February 17, 1999.
- Subsequently, the Company name was changed from Sai Dru Syn Laboratories Limited' to Sai Life Sciences Limited' dated December 16, 2003. Thereafter, the name of the Company was changed from Sai Life Sciences Limited' to Sai Advantium Pharma Limited' dated August 30, 2006 issued by the Registrar of Companies, Andhra Pradesh.
- Subsequently, the Company name was changed from Sai Advantium Pharma Limited' to Sai Life Sciences Limited' and a fresh Certificate of Incorporation dated May 28, 2012 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
Sai Life Sciences Ltd News Hub
Sai Life Sciences IPO subscribed 10.26 times
The initial public offer (IPO) of Sai Life Sciences received bids for 39,85,59,663 shares as against
Read more
13 Dec 24
Sai Life Sciences IPO ends with 10.26x subscription
The initial public offer (IPO) of Sai Life Sciences received bids for 39,85,59,528 shares as against
Read more
16 Dec 24
Sai Life Sciences spurts on debut
The scrip was listed at Rs 660, exhibiting a premium of 20.22% to the issue price. So far, the stock
Read more
18 Dec 24
Sai Life Sciences IPO subscribed 84%
The initial public offer (IPO) of Sai Life Sciences received bids for 3,27,98,169 shares as against
Read more
11 Dec 24